Investing.com - Boston Scientific (NYSE:BSX) reported on Tuesday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Boston Scientific announced earnings per share of $0.4 on revenue of $3.08B. Analysts polled by Investing.com anticipated EPS of $0.3728 on revenue of $2.94B.
Boston Scientific shares are up 1% from the beginning of the year and are trading at $43.97 , down-from-52-week-high.They are under-performing the S&P 500 which is up 17.74% from the start of the year.
Boston Scientific follows other major Healthcare sector earnings this month
Boston Scientific's report follows an earnings beat by J&J on Wednesday, July 21, 2021, who reported EPS of $2.48 on revenue of $23.31B, compared to forecasts EPS of $2.29 on revenue of $22.49B.
UnitedHealth had beat expectations on Thursday, July 15, 2021 with second quarter EPS of $4.7 on revenue of $71.32B, compared to forecast for EPS of $4.43 on revenue of $69.51B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar